Distance to the neurooncological centre: a new prognostic parameter in GBM patients?

J. Kerschbaumer, C.F. Freyschlag, R. Bauer, A.A. Obwegeser, C. Thomé & M. Seiz
Objective: Regardless of current multimodal treatment strategies patients harbouring glioblastoma multiforme (GBM) still have a dismal prognosis. The introduction of concomitant and adjuvant temozolomide that shows a lower toxicity profile compared to previous nitrosourea based chemotherapy in 2005 [for full text, please go to the a.m. URL]